CoChat

Three-Year Outcomes of Bariatric Surgery in Patients With Obesity and Hypertension: A Randomized Clinical Trial

Schiavon, Carlos A., Bhatt, Deepak L., Ikeoka, Dimas, Santucci, Eliana V., Santos, Renato Nakagawa, Damiani, Lucas P., Oliveira, Juliana D., Machado, Rachel Helena V., Halpern, Helio, Monteiro, Frederico L.J., Noujaim, Patricia M., Cohen, Ricardo V., de Souza, Marcio G., Amodeo, Celso, Bortolotto, Luiz A., Berwanger, Otavio, Cavalcanti, Alexandre B., Drager, Luciano F. · 2020 · Annals of Internal Medicine
Cited by 94

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Background: Midterm effects of bariatric surgery on patients with obesity and hypertension remain uncertain. Objective: To determine the 3-year effects of Roux-en-Y gastric bypass (RYGB) on blood pressure (BP) compared with medical therapy (MT) alone. Design: Randomized clinical trial. (ClinicalTrials.gov: NCT01784848) Setting: Investigator-initiated study at Heart Hospital (HCor), São Paulo, Brazil. Participants: Patients with hypertension receiving at least 2 medications at maximum doses or more than 2 medications at moderate doses and with a body mass index (BMI) between 30.0 and 39.9 kg/m2 were randomly assigned (1:1 ratio). Intervention: RYGB plus MT or MT alone. Measurements: The primary outcome was at least a 30% reduction in total number of antihypertensive medications while maintaining BP less than 140/90 mm Hg. Key secondary outcomes were number of antihypertensive medications, hypertension remission, and BP control according to current guidelines (<130/80 mm Hg). Results: Among 100 patients (76% female; mean BMI, 36.9 kg/m2 [SD, 2.7]), 88% from the RYGB group and 80% from the MT group completed follow-up. At 3 years, the primary outcome occurred in 73% of patients from the RYGB group compared with 11% of patients from the MT group (relative risk, 6.52 [95% CI, 2.50 to 17.03]; P < 0.001). Of the randomly assigned participants, 35% and 31% from the RYGB group and 2% and 0% from the MT group achieved BP less than 140/90 mm Hg and less than 130/80 mm Hg without medications, respectively. Median (interquartile range) number of medications in the RYGB and MT groups at 3 years was 1 (0 to 2) and 3 (2.8 to 4), respectively (P < 0.001). Total weight loss was 27.8% and −0.1% in the RYGB and MT groups, respectively. In the RYGB group, 13 patients developed hypovitaminosis B12 and 2 patients required reoperation. Limitation: Single-center, nonblinded trial. Conclusion: RYGB is an effective strategy for midterm BP control and hypertension remission, with fewer medications required in patients with hypertension and obesity. Primary Funding Source: Ethicon, represented in Brazil by Johnson & Johnson do Brasil.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/m19-3781

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 94

Metadata

Authors
Schiavon, C. A., Bhatt, D. L., Ikeoka, D., Santucci, E. V., Santos, R. N., Damiani, L. P., Oliveira, J. D., Machado, R. H. V., Halpern, H., Monteiro, F. L. J., Noujaim, P. M., Cohen, R. V., de Souza, M. G., Amodeo, C., Bortolotto, L. A., Berwanger, O., Cavalcanti, A. B., & Drager, L. F.
Venue
Annals of Internal Medicine
Published
2020-11-03
Volume
173
Issue
9
Pages
685-693
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W3055466658
Cited by
94
References
19
FWCI
10.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Three-Year Outcomes of Bariatric Surgery in Patients With Obesity and Hypertension: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.7326/m19-3781
The paper
Schiavon, C. A., Bhatt, D. L., Ikeoka, D., Santucci, E. V., Santos, R. N., Damiani, L. P., Oliveira, J. D., Machado, R. H. V., Halpern, H., Monteiro, F. L. J., Noujaim, P. M., Cohen, R. V., de Souza, M. G., Amodeo, C., Bortolotto, L. A., Berwanger, O., Cavalcanti, A. B., & Drager, L. F. (2020). Three-Year Outcomes of Bariatric Surgery in Patients With Obesity and Hypertension: A Randomized Clinical Trial. Annals of Internal Medicine. https://doi.org/10.7326/m19-3781

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.